Le Lézard
Classified in: Health
Subjects: AWD, PET

Saint Francis Veterinary Center of South Jersey Wins Accredited Practice of the Year, Named a Finalist for Unprecedented Third Time

WOOLWICH TOWNSHIP, N.J., Sept. 16, 2019 /PRNewswire/ -- Saint Francis Veterinary Center of South Jersey was named Accredited Practice of the Year in North America for 2019, the veterinary profession's highest honor awarded each year to the leading accredited animal hospital in the United States and Canada by the American Animal Hospital Association (AAHA).

Saint Francis Veterinary Center of South Jersey

The Accredited Practice of the Year Award recognizes the outstanding achievements of accredited veterinary practice teams and celebrates ongoing advancements in veterinary medicine. The AAHA Awards Committee evaluates each hospital team on its most recent accreditation scores, medical excellence, mission and vision, practice team composition, continuing education and training, community service and other categories of excellence.  Fewer than 12% of North America's 29,000 veterinary practices earn accreditation by AAHA. Saint Francis has been accredited for more than 25 years, reflecting a continued level of veterinary excellence rarely achieved by animal hospitals in North America.

"For all of us here at Saint Francis, we are humbled beyond words to receive this honor," said Dr. Mark F. Magazu, DVM, Founder of Saint Francis Veterinary Center of South Jersey. "We strive to provide the highest level of care for our pets at all times. This continued recognition is something that all of us will cherish for the rest of our careers."

Saint Francis has previously been a Finalist for Accredited Practice of the Year in 2012 for general medicine and in 2014 for referral medicine, making Saint Francis the only three-time nominee for the award in the industry's history.

For more information or to make an appointment at Saint Francis Veterinary Center of South Jersey please visit www.SaintFrancis.org or call 856.467.0050.

About Saint Francis Veterinary Center of South Jersey
Founded in 1986, Saint Francis Veterinary Center of South Jersey is an award-winning 24-hour emergency and specialty referral practice. Saint Francis has twice been a Top 2 Finalist for Practice of the Year in North America, honored by the American Animal Hospital Association. The practice was New Jersey's first certified Level II 24 hour emergency center for animals, recognized by the Veterinary Emergency and Critical Care Society. In 2013, Saint Francis was recognized with a Certificate of Special Senate Recognition for "innovative veterinary care and outstanding contributions to the community." For more information please visit www.SaintFrancis.org.

About AAHA
The American Animal Hospital Association is the only organization that accredits companion animal practices throughout the United States and Canada according to high standards of veterinary care. AAHA-accredited hospitals are recognized among the finest in the industry and are consistently at the forefront of advanced veterinary medicine. Pet owners look for AAHA-accredited hospitals because they value their pet's health and trust the consistent, expert care provided by the entire health care team. For more information about AAHA, visit aaha.org.

SOURCE Saint Francis Veterinary Center of South Jersey

These press releases may also interest you

at 01:05
Sartorius, a leading international partner of biopharmaceutical research and the industry, performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months....

at 01:05
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced results from a retrospective chart review study (EVOLVE), which investigated the likelihood of serious adverse events and serious infections with vedolizumab and...

at 01:05
Sartorius, a leading partner to the biopharmaceutical industry and laboratories, has signed an agreement to acquire parts of Danaher's Life Science portfolio for approximately $750 million in cash. The businesses had combined sales turnover of...

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III IMbrave150 study, evaluating Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) as a treatment for people with unresectable...

at 00:10
Verseau Therapeutics, Inc. ("Verseau") launched today with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua...

20 oct 2019
Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today...

News published on 16 september 2019 at 12:35 and distributed by: